Yuichiro Inatomi Selected Research

Yuichiro Inatomi Research Topics

11	Stroke (Strokes) 01/2022 - 10/2002
8	Ischemic Stroke 07/2021 - 04/2005
4	Embolic Stroke 05/2018 - 10/2005
3	Atrial Fibrillation 01/2022 - 04/2005
2	Guillain-Barre Syndrome 07/2021 - 10/2019
2	Brain Diseases (Brain Disorder) 03/2020 - 07/2008
2	Thrombosis (Thrombus) 01/2015 - 10/2005
1	Leukoencephalopathies 12/2022
1	Hypertension (High Blood Pressure) 12/2022
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 12/2022
1	Edema (Dropsy) 12/2022
1	Quadriplegia (Spastic Quadriplegia) 09/2020
1	Hematoma 09/2020
1	Hyperalgesia 09/2020
1	Intracranial Embolism 05/2018
1	Hemiplegia (Spastic Hemiplegia) 05/2018
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2016
1	Unconsciousness (Loss of Consciousness) 07/2008
1	Hypercholesterolemia 07/2008
1	Leukocytosis (Pleocytosis) 07/2008
1	Glioblastoma (Glioblastoma Multiforme) 07/2008
1	Cerebral Infarction 04/2006
1	Gingivitis 02/2006
1	Dental Caries (Decay, Dental) 02/2006
1	Meningitis 02/2006
1	Bacteremia 02/2006
1	Fever (Fevers) 02/2006
1	Transient Ischemic Attack 06/2005
1	Orthostatic Hypotension (Postural Hypotension) 04/2005
1	Pathologic Constriction (Stenosis) 04/2005
1	Coma (Comas) 04/2005
1	Hepatic Encephalopathy 03/2005
1	Prostatic Neoplasms (Prostate Cancer) 03/2005
1	Blindness (Hysterical Blindness) 01/2005
1	Brain Infarction 10/2002
1	Paresis (Hemiparesis) 07/2002

5	AnticoagulantsIBA 01/2022 - 07/2010
2	SteroidsIBA 07/2021 - 10/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2021 - 10/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2020 - 07/2008
2	EdaravoneIBA 01/2018 - 01/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2006 - 01/2005
1	ApolipoproteinsIBA 12/2022
1	Apolipoproteins E (ApoE)IBA 12/2022
1	Antihypertensive Agents (Antihypertensives)IBA 12/2022
1	Amyloid (Amyloid Fibrils)IBA 12/2022
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 01/2022
1	Vitamin K FDA Link 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 07/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	anti-thyroglobulinIBA 03/2020
1	AntibodiesIBA 03/2020
1	Iodide Peroxidase (Deiodinase)IBA 03/2020
1	Methylprednisolone FDA LinkGeneric 03/2020
1	Blood Glucose (Blood Sugar)IBA 07/2018
1	LDL CholesterolIBA 07/2018
1	Triglycerides (Triacylglycerol)IBA 07/2018
1	Hemoglobins (Hemoglobin)IBA 07/2018
1	afliberceptIBA 05/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2018
1	Neuroprotective AgentsIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	NR2B NMDA receptorIBA 07/2008
1	Proteins (Proteins, Gene)FDA Link 07/2008
1	Glutamate Receptors (Glutamate Receptor)IBA 07/2008
1	AutoantibodiesIBA 07/2008
1	AminesIBA 12/2005
1	OximesIBA 12/2005
1	hydroxide ionIBA 04/2005
1	Chlormadinone Acetate (Chlormadinone)IBA 03/2005
1	AmmoniaIBA 03/2005
1	nafamostatIBA 01/2005
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2002

7	Therapeutics 01/2022 - 01/2005
2	Length of Stay 06/2005 - 10/2002
1	Thrombolytic Therapy 11/2020
1	Laminectomy 09/2020
1	Immunotherapy 03/2020
1	Intravitreal Injections 05/2018
1	Endarterectomy (Thromboendarterectomy) 01/2015
1	Gastrostomy 01/2012
1	Home Nursing (Nursing, Home) 07/2008
1	Decompressive Craniectomy 04/2006
1	Dental Scaling 02/2006
1	Intravenous Infusions 01/2006
1	Carotid Endarterectomy 10/2005
1	Early Ambulation 04/2005
1	Prostatectomy (Retropubic Prostatectomy) 03/2005
1	Enteral Nutrition (Feeding, Tube) 10/2002